Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Imiquimod 5% cream is an approved treatment for actinic keratoses, superficial basal cell carcinomas, and anogenital warts. Severe systemic side effects associated with imiquimod 5% cream are rare, although a few cases of erythema multiforme and Stevens-Johnson syndrome have been described. We present a case of Stevens-Johnson syndrome associated with topical treatment with imiquimod of two superficial basal cell carcinomas.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11694421 | PMC |
| http://dx.doi.org/10.4081/dr.2024.9930 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Local Chemotherapy of Skin Pre-Neoplastic Lesions and Malignancies from the Perspective of Current Pharmaceutics.
Pharmaceutics
August 2025
Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 9000 Varna, Bulgaria.
In the preceding and early stages of cancer progression, local drug delivery to pre-cancerous and cancerous skin lesions may be applied as an alternative or supplementary therapy. At present, 5-Fluorouracil, imiquimod, and tirbanibulin creams and ointments have established their place in practice, while several other active pharmaceutical ingredients (APIs) (e.g.
View Article and Find Full Text PDFRandomized clinical trial comparing removal followed by topical imiquimod versus removal followed by topical methylprednisolone in the treatment of keloids.
Acta Cir Bras
August 2025
Universidade Federal do Rio de Janeiro - Postgraduate Program in Dermatology - Rio de Janeiro (RJ) - Brazil.
Purpose: Keloids are unaesthetic benign dermatosis characterized by a disorganized proliferation of collagen. Treatment of keloids constitutes a therapeutic challenge. The aim of this study was to evaluate the efficacy and effectiveness of topical imiquimod associated with surgical excision in the treatment of keloid.
View Article and Find Full Text PDFThe Therapeutic Potential of for Psoriasis: A Combined Phytochemical, In Silico, and Experimental Approach.
Int J Mol Sci
July 2025
Department of Physiology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, 34000 Kragujevac, Serbia.
Psoriasis is a chronic inflammatory skin disorder involving oxidative stress and immune dysregulation. Given the limitations and adverse effects of conventional therapies, interest in natural treatments with anti-oxidant and immunomodulatory properties is increasing. This study aimed to comprehensively evaluate the therapeutic potential of extract in an imiquimod-induced rat model of psoriasis.
View Article and Find Full Text PDFDermoscopy and Ultraviolet Reflectance Dermoscopy of Benign Lichenoid Keratosis Masquerading as Melanoma.
Indian Dermatol Online J
September 2025
Department of Dermatology, Venereology and Leprosy, SRM Medical College Hospital and Research Centre, Kattankulathur Campus, Chengalpattu, Tamil Nadu, India.
Benign lichenoid keratosis (BLK), also known as lichen planus-like keratosis, is a benign cutaneous lesion of unknown etiology with overlapping clinical and dermoscopic features with malignant lesions. A 52-year-old female presented with a 10- years history of a single asymptomatic lesion on the left gluteal region not associated with loss of weight, loss of appetite, or other systemic symptoms. Clinical examination revealed a single well-defined violaceous to hyperpigmented plaque of approximately 4 cm × 3 cm in size, on the lateral aspect of the left gluteal region.
View Article and Find Full Text PDFBeyond the application site: A case of imiquimod-induced cytokine-mediated systemic symptoms.
Int J STD AIDS
August 2025
Department of Dermatology, Civil Hospital, Nabha, India.
Topical imiquimod is widely used for the treatment of external anogenital warts due to its potent immunomodulatory effects. Although local skin reactions are common, systemic side effects are rare and under-recognized. We describe the case of a 23-year-old male who developed recurrent, cytokine-mediated systemic symptoms-including fever, myalgias, and malaise-within hours of each application of imiquimod 5% cream to condylomata acuminata on the glans penis and inner prepuce.
View Article and Find Full Text PDF